TORONTO--(BUSINESS WIRE)--In a significant advancement in stroke care, The Ottawa Hospital (TOH) has successfully adopted Vena Medical's Balloon Distal Access Catheter (BDAC™) into its stroke treatment protocol. This follows a comprehensive evaluation through OBIO's Early Adopter Health Network (EAHN™), highlighting a leap forward in mechanical thrombectomy effectiveness..

多伦多--（商业新闻短讯）--渥太华医院（TOH）在中风治疗方面取得了重大进展，成功地将Vena Medical的球囊远端通路导管（BDAC™）纳入其中风治疗方案。这是通过OBIO的早期采用者健康网络（EAHN™）进行的综合评估，突出了机械血栓切除术有效性的飞跃。。

The Vena BDAC™ combines balloon guide and distal access catheter technologies to significantly improve the First Pass Effect (FPE) in the treatment of acute ischemic stroke (AIS), a life-threatening and debilitating condition. FPE is the successful removal of a blood clot on the first attempt during thrombectomy, which is vital for reducing brain damage.

Vena BDAC™结合了球囊引导和远端通路导管技术，可显着改善急性缺血性卒中（AIS）治疗中的首过效应（FPE），这是一种危及生命和衰弱的疾病。FPE是血栓切除术中第一次尝试成功去除血块，这对于减少脑损伤至关重要。

By enhancing this critical factor, the BDAC™ seeks to decrease the debilitating effects and mortality associated with strokes, thereby improving recovery times and overall patient outcomes. This advancement addresses the pressing health and economic challenges of stroke care, offering a promising improvement for those affected by this serious health issue..

通过增强这一关键因素，BDAC™旨在降低与中风相关的衰弱效应和死亡率，从而改善恢复时间和总体患者预后。这一进步解决了中风护理面临的紧迫健康和经济挑战，为受这一严重健康问题影响的人提供了有希望的改善。。

The recent evaluation at TOH indicated significant improvements in stroke treatment outcomes with Vena Medical's BDAC™. FPE increased to 64%, well above the industry average of 44%. These results suggest notable improvements in patient health at the 90-day mark, particularly in terms of functional independence.

TOH最近的评估表明，使用Vena Medical的BDAC™可以显着改善中风治疗结果。FPE增至64%，远高于行业平均水平44%。这些结果表明，在90天的时间里，患者的健康状况有了显着改善，特别是在功能独立性方面。

The adoption of the BDAC™ at TOH highlights its vital role in enhancing stroke care and improving treatment outcomes..

TOH采用BDAC™突显了其在加强中风护理和改善治疗效果方面的重要作用。。

Michael Phillips, Vena Medical’s Co-founder and CEO, remarked, “It's great to see The Ottawa Hospital putting themselves on the map as an early adopter and champion of innovation in Canada. Through EAHN™, TOH is the first in the world to adopt Vena Medical's latest stroke technology, the Vena Balloon Distal Access Catheter as their device of choice.

Vena Medical联合创始人兼首席执行官迈克尔·菲利普斯（MichaelPhillips）表示：“很高兴看到渥太华医院作为加拿大的早期采用者和创新倡导者登上地图。通过EAHN™，TOH是世界上第一个采用Vena Medical最新中风技术的人，将Vena球囊远端通路导管作为他们的首选设备。

Canadians continue to be the first to benefit from this cost lowering and outcome improving technology developed right in their backyards before it takes the rest of the world by storm.”.

加拿大人仍然是第一个从这种降低成本和提高成果的技术中受益的人，这种技术是在他们的后院开发的，而不是在它席卷世界其他地区之前。”。

“The Ottawa Hospital is always focused on enhancing patient outcomes through innovative solutions,” said Ellen Odai Alie, Director of Medical Imaging at The Ottawa Hospital. “Integrating Vena Medical’s BDAC into our treatment protocol means that more patients can be treated successfully on the first try – marking a significant advancement in stroke care.”.

渥太华医院医学影像主任艾伦·奥代·阿里（EllenOdaiAlie）表示：“渥太华医院始终致力于通过创新解决方案提高患者的治疗效果。”。“将Vena Medical的BDAC纳入我们的治疗方案意味着更多的患者可以在第一次尝试中成功治疗，这标志着中风护理取得了重大进展。”。

“OBIO® is pleased to support the adoption of Vena Medical’s latest stroke technology at The Ottawa Hospital through EAHN™,” said Dr. Maura Campbell, President and CEO of OBIO®. “This project exemplifies how EAHN™ can introduce innovative technologies across the healthcare system to improve treatment outcomes and recovery times for serious conditions, including stroke.”.

“OBIO®很高兴通过EAHN™支持渥太华医院采用Vena Medical最新的中风技术，”OBIO®总裁兼首席执行官莫拉·坎贝尔博士表示。。

About Vena Medical

关于Vena Medical

Vena Medical, an ISO 13485 and MDSAP certified company, is creating a suite of tools to change the way physicians perform minimally invasive neurosurgery, starting with the Vena Balloon Distal Access Catheter™, currently available in Canada. The MicroAngioscope™ is the smallest camera in the world, designed for physicians to view inside veins and arteries for stroke treatment.

Vena Medical是一家通过ISO 13485和MDSAP认证的公司，它正在开发一套工具来改变医生进行微创神经外科手术的方式，首先是目前在加拿大上市的Vena Balloon远端通路导管™。MicroAngioscope™是世界上最小的相机，专为医生设计，用于查看中风治疗的静脉和动脉内部。

The need for this new product has been evident in stroke treatment through pre-clinical studies published in the American Journal of NeuroRadiology and the Journal of NeuroInterventional Surgery..

通过发表在《美国神经放射学杂志》和《神经介入外科杂志》上的临床前研究，中风治疗中对这种新产品的需求显而易见。。

For more information on Vena Medical visit www.venamed.ca

有关Vena Medical的更多信息，请访问www.venamed.ca

About The Ottawa Hospital

关于渥太华医院

The Ottawa Hospital (TOH) is one of Canada’s top learning and research hospitals where we are guided by our vision to provide the world-class and compassionate care we would all want for our loved ones.

渥太华医院（TOH）是加拿大顶尖的学习和研究医院之一，我们以我们的愿景为指导，为我们的亲人提供我们都想要的世界级和富有同情心的护理。

Our multi-campus hospital, affiliated with the University of Ottawa, is home to the Regional Trauma Centre and Cancer Centre, and to discoveries that are adopted globally.

。

Backed by generous support from the community, we are focused on reshaping the future of health care to improve the health of our diverse population of patients from Eastern Ontario, Western Quebec, and Nunavut.

。

For more information about The Ottawa Hospital, visit OttawaHospital.on.ca.

有关渥太华医院的更多信息，请访问OttawaHospital.on.ca。

About OBIO®

关于OBIO®

OBIO®, a not-for-profit, membership-based organization dedicated to advancing health technology innovation and commercialization, is prioritizing the evaluation of new technologies through its Early Adopter Health Network (EAHN™). OBIO® is engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies, positioning Canada as a leader in the international marketplace.

OBIO®是一家非营利性的会员制组织，致力于推进卫生技术创新和商业化，目前正通过其早期采用者健康网络（EAHN™）优先评估新技术。OBIO®致力于战略、规划、政策制定和宣传，以推动人类健康技术的商业化，使加拿大成为国际市场的领导者。

For more information, please visit OBIO.ca and follow OBIO® on LinkedIn and X..

有关更多信息，请访问OBIO.ca并在LinkedIn和X上关注OBIO®。。